Sherwin-Williams Paint Shield offers antibacterial protection against MRSA
MRSA, or methicillin-resistant Staphylococcus aureus, is a bacteria highly resistant to antibiotics and causes tens of thousands of invasive infections every year in Americans, often in hospital or nursing home settings. Patients who may be susceptible to any bacterial infections of this type will be able to breathe a great sigh of relief thanks to a new paint formula developed by Sherwin-Williams Co. (NYSE:SHW) of Cleveland, OH. The buildings material developer, known primarily for its paint products, announced at the end of October a new antimicrobial paint formulation known as Paint Shield which will begin selling in the first quarter of 2016. A Sherwin-Williams press release states that this is the first U.S. Environmental Protection Agency-registered paint capable of killing up to 99.99 percent of staph, MRSA, E. coli and other infection-causing bacteria within two hours of the bacteria’s exposure to the paint.